DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing contract ...
The biopharmaceutical industry faces a continuous pressure to deliver innovative treatments in a safe and appropriate manner, including the rapidly growing area of therapeutic antibodies. However, the ...
VHH antibodies, they’re not just small, they're modular engineering platforms, capable of powerful biological activity. But ...
Monoclonal antibodies (mAbs) have revolutionized cancer therapy due to their ability to specifically target tumor cells while sparing healthy ones. These biologics have become indispensable in ...
HUNTSVILLE, AL, April 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug ...
CMAB completed a full scope development and manufacturing project for Q-1802 in 9 months for dual IND filing in China and the US Completion of the project demonstrates the significant speed to clinic ...
At the “Biological Production Forum” held recently in Dusseldorf, there were many lessons for those involved in monoclonal antibody manufacturing. In a wide-ranging presentation, Günter Jagschies, ...
Many antibody drugs are on the market, including the leukemia therapy Arzerra, developed by Genmab and its partner GlaxoSmithKline. But despite antibodies’ high specificity for cellular targets, not ...
To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...
CHAPEL HILL, N.C.--(BUSINESS WIRE)--Cessation Therapeutics, Inc. (“Cessation), a clinical-stage biotechnology company advancing biologics that target substances of abuse, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results